- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk Smoldering Multiple Myeloma in United States
Total 2361 results
-
University of Alabama at BirminghamEnrolling by invitationHigh Risk Pregnancy | Bone MarrowUnited States
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Schrödinger, Inc.RecruitingAcute Myeloid Leukemia | High-Risk and Very High-Risk Myelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Recurrent Acute Biphenotypic Leukemia | Blasts 20 Percent or More of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk...United States
-
The University of Texas Health Science Center,...Not yet recruitingNutrition in High-Risk PregnancyUnited States
-
Magenta Medical Ltd.RecruitingHigh-risk Percutaneous Coronary InterventionUnited States
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer Research...CompletedSmoldering Multiple MyelomaUnited States
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
University of ChicagoNorthwestern University; University of Illinois at Chicago; Rush University Medical... and other collaboratorsActive, not recruitingMedicare Patients | High Risk of HospitalizationsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHigh Risk for Postoperative Cardiovascular EventsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Abiomed Inc.Active, not recruitingHigh-risk Percutaneous Coronary InterventionUnited States
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
University of RochesterAmgenActive, not recruiting
-
Queens College, The City University of New YorkState University of New York at BuffaloTerminatedParenting | Prevention | Child Maltreatment | Fathers | High-riskUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Amyloidosis | Waldenstrom's Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
OncoPep, Inc.CompletedSmoldering Multiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
Massachusetts General HospitalCelgene; OncoPep, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
VA Office of Research and DevelopmentRecruitingOlder Men and Women With High Fall RiskUnited States
-
Abiomed Inc.CompletedPatients Undergoing High Risk PCI.United States, Netherlands
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Mixed Phenotype Acute LeukemiaUnited States
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
Johns Hopkins UniversityCompletedCommunication | Obstetric Complication | High Risk Pregnancy | Multidisciplinary CommunicationUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer Survivors | Statin Use Among High Risk SurvivorsUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
Edwards LifesciencesActive, not recruiting
-
University of PennsylvaniaCompletedPregnancy, High RiskUnited States
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedHigh Risk Acute Myeloid LeukemiaUnited States, Canada
-
Dana-Farber Cancer InstituteCompletedMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterRecruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
University of MiamiRecruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
University of California, IrvineRecruitingPregnancy, High Risk | AnticoagulantsUnited States
-
Abiomed Inc.Enrolling by invitationHigh-Risk Percutaneous Coronary InterventionUnited States
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Verinata Health, Inc.Completed
-
Wake Forest University Health SciencesCompletedUnplanned Hospital Readmissions | Patients at High Risk of Unplanned ReadmissionUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
University of PennsylvaniaRecruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM)United States
-
Dana-Farber Cancer InstituteJanssen Pharmaceuticals; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsActive, not recruitingSmoldering Multiple Myeloma | Monoclonal GammopathyUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
International Myeloma FoundationJanssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Masonic Cancer Center, University of MinnesotaUniversity of MinnesotaWithdrawnSecondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Treatment-Related Acute Myeloid Leukemia | High-Risk Acute Myeloid LeukemiaUnited States